| Product Code: ETC8603967 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Niger`s import shipments of gadolinium-based contrast media in 2024 continued to be dominated by key exporters such as France, China, Denmark, Switzerland, and South Africa. Despite a decrease in the growth rate from 2023 to 2024, the market still exhibited high concentration levels, with the Herfindahl-Hirschman Index (HHI) remaining at a significant level. The compound annual growth rate (CAGR) for the period 2020-2024 was negative at -1.61%, indicating a challenging market environment. The decline in growth rate from 2023 to 2024 further highlights the need for continued monitoring and strategic planning in this sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Niger Gadolinium-based Contrast Media Market Overview |
3.1 Niger Country Macro Economic Indicators |
3.2 Niger Gadolinium-based Contrast Media Market Revenues & Volume, 2021 & 2031F |
3.3 Niger Gadolinium-based Contrast Media Market - Industry Life Cycle |
3.4 Niger Gadolinium-based Contrast Media Market - Porter's Five Forces |
3.5 Niger Gadolinium-based Contrast Media Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Niger Gadolinium-based Contrast Media Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.7 Niger Gadolinium-based Contrast Media Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Niger Gadolinium-based Contrast Media Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring diagnostic imaging procedures |
4.2.2 Technological advancements in imaging techniques using gadolinium-based contrast media |
4.2.3 Rising demand for accurate and early diagnosis leading to the use of contrast agents |
4.3 Market Restraints |
4.3.1 Potential health risks associated with gadolinium retention in the body |
4.3.2 Stringent regulatory requirements for the approval and use of contrast agents |
4.3.3 High cost associated with gadolinium-based contrast media leading to limited affordability |
5 Niger Gadolinium-based Contrast Media Market Trends |
6 Niger Gadolinium-based Contrast Media Market, By Types |
6.1 Niger Gadolinium-based Contrast Media Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Extracellular agents, 2021- 2031F |
6.1.4 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Blood pool agents, 2021- 2031F |
6.1.5 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Hepatobiliary agents, 2021- 2031F |
6.2 Niger Gadolinium-based Contrast Media Market, By Modality |
6.2.1 Overview and Analysis |
6.2.2 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By MRI, 2021- 2031F |
6.2.3 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By MRA, 2021- 2031F |
6.3 Niger Gadolinium-based Contrast Media Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.3 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Neurology, 2021- 2031F |
6.3.4 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.5 Niger Gadolinium-based Contrast Media Market Revenues & Volume, By Others (Musculoskeletal), 2021- 2031F |
7 Niger Gadolinium-based Contrast Media Market Import-Export Trade Statistics |
7.1 Niger Gadolinium-based Contrast Media Market Export to Major Countries |
7.2 Niger Gadolinium-based Contrast Media Market Imports from Major Countries |
8 Niger Gadolinium-based Contrast Media Market Key Performance Indicators |
8.1 Rate of adoption of gadolinium-based contrast media in diagnostic imaging procedures |
8.2 Number of research studies validating the efficacy and safety of gadolinium-based contrast media |
8.3 Investment in research and development for developing next-generation contrast agents |
9 Niger Gadolinium-based Contrast Media Market - Opportunity Assessment |
9.1 Niger Gadolinium-based Contrast Media Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Niger Gadolinium-based Contrast Media Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.3 Niger Gadolinium-based Contrast Media Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Niger Gadolinium-based Contrast Media Market - Competitive Landscape |
10.1 Niger Gadolinium-based Contrast Media Market Revenue Share, By Companies, 2024 |
10.2 Niger Gadolinium-based Contrast Media Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |